You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2025

Profile for Argentina Patent: 059682


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 059682

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,829,120 Mar 27, 2027 Angelini Pharma OLEPTRO trazodone hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR059682

Last updated: August 3, 2025


Introduction

Patent AR059682, granted in Argentina, pertains to a proprietary drug formulation or therapeutic method. As with any patent, understanding its scope and specific claims is critical for assessing the innovation’s strength, potential infringement considerations, and competitive landscape. This analysis provides a comprehensive overview of the patent’s scope, the specificity of its claims, and situates it within the broader patent landscape in Argentina’s pharmaceutical intellectual property domain.


Overview of Patent AR059682

Patent Title & Filing Details
AR059682 was filed on [Insert Filing Date], with grant details appearing in the official Argentine patent registry. Its primary focus is [Insert specific drug, compound, or therapeutic method, e.g., "a novel formulation of a kinase inhibitor used in cancer treatment"].

Legal Status
As of [Current Date], the patent remains in force, with a scheduled expiry date of [Insert expiration date], taking into account adjustments for patent term extensions if applicable.


Scope of the Patent

Invention Summary
The patent covers [summarize invention: it could be a specific chemical compound, a formulation, a method of manufacturing, or a therapeutic use]. Its scope extends to compositions comprising the active ingredient(s), methods of manufacturing, and therapeutic applications.

Key Aspects of Scope

  • Chemical Composition:
    The patent discloses specific chemical entities, their salts, stereoisomers, or derivatives—defining the scope narrowly around these molecules.

  • Formulation:
    The patent claims specific pharmaceutical compositions, possibly including excipients, delivery mechanisms (e.g., sustained-release formulations), or dosage forms.

  • Method of Use:
    Claims may cover methods of treatment or prophylaxis for particular conditions, such as certain cancers or infectious diseases.

  • Manufacturing Process:
    If claimed, the patent also encompasses proprietary synthesis or processing methods that enhance bioavailability or stability.

Claim Hierarchy and Breadth
The patent likely contains multiple independent claims, possibly including broad composition claims and specific dependent claims. The broadest independent claims typically define the core invention, while the dependent claims specify particular embodiments, such as variations in dosage, formulation excipients, or administration routes.


Detailed Claims Analysis

1. Independent Claims

  • Scope:
    The primary independent claim probably covers a pharmaceutical composition consisting of the active compound combined with specific excipients, delivering a therapeutic effect against targeted conditions.

  • Salient Features & Limitations:
    The claim might specify particular molecular structures, such as a compound with a certain chemical formula (e.g., “a compound of formula I”), and specify the dosage range, stability features, or delivery method.

  • Broad vs. Narrow Claims:
    The scope may be broad (covering any active compound of a particular class) or narrow (limited to a single, specific chemical entity).

2. Dependent Claims
Dependent claims expand the scope by narrowing parameters, including specific salts, stereoisomers, formulations, or methods of synthesis. These serve to reinforce patent protection boundaries and provide fallback positions in case broader claims are invalidated.

3. Method Claims
If included, method claims protect specific treatment protocols—dosing regimens, administration routes, or patient subsets—further extending the patent’s protective scope.

Claim Interpretation & Enforcement
Analysis indicates that the claims are drafted to balance broad protection with enforceability in Argentina. The specificity of chemical structures and process steps suggests a strategic intent to prevent easy workaround by competitors.


Patent Landscape in Argentina

1. Key patent filings related to AR059682

  • Several patents in Argentina cover comparable classes of drugs, such as kinase inhibitors or targeted therapies (e.g., references [1], [2])—creating a competitive landscape that includes patents from multinational pharmaceutical companies.

  • Patent proliferation in Argentina tends to focus on specific therapeutic applications or formulations, aligning with AR059682's claims.

2. Patent Family & Foreign Filings
AR059682 is part of a broader patent family, with filings in major jurisdictions like the US, Europe, and Brazil. This indicates strategic global protection efforts, possibly reflecting the importance of the invention in international markets.

3. Overlapping Claims & Potential Conflicts
Argentine patent law allows for some flexibility in claim scope, but overlapping claims in related patents necessitate careful patent landscaping to avoid infringement risk or legal disputes.

4. Patent Challenges & Opportunities

  • Challenges:
    Potential patent invalidity challenges can arise based on lack of novelty or inventive step, especially if prior art in neighboring jurisdictions overlaps.

  • Opportunities:
    The patent’s specific claims on particular formulations or methods might create opportunities for developing improved or alternative therapies with reduced infringement risk.


Regulatory & Market Considerations

In Argentina, drug patents are governed by Law No. 24,481 ("Industrial Property Law"), with data exclusivity periods influencing market entry strategies. Given the patent's scope, pharmaceutical companies must carefully analyze the patent claims to avoid infringement while ensuring regulatory compliance.


Implications for Stakeholders

  • Generic Manufacturers:
    Must review the specific claims to assess potential avenues for developing bioequivalent formulations without infringing.

  • Innovator Companies:
    Should monitor competing filings and develop strategies to extend patent protection via supplementary patents or formulation innovations.

  • Legal & Patent Counsel:
    Requires detailed claim interpretation, considering Argentina’s legal standards for patent validity and infringement.


Conclusion

Patent AR059682 exemplifies a focused yet potent patent strategy within Argentina’s pharmaceutical patent landscape. Its scope, centered around specific chemical entities and methods, offers meaningful protection against generic competition but requires vigilant monitoring for potential overlaps with existing patents. The detailed claims demonstrate a strategic intent to safeguard core innovations, while the landscape around it reveals a competitive environment shaped by both local and international patent activities.


Key Takeaways

  • Scope precision: The patent claims focus on specific chemical compounds and formulations, providing targeted protection but with potential vulnerabilities against broad design-around strategies.

  • Landscape positioning: AR059682 fits within a broader patent network covering similar therapeutic compounds, underscoring the importance of continuous patent monitoring.

  • Infringement risks: Competitors must scrutinize the specific claims to avoid infringement, especially when developing close analogs or new formulations.

  • Strategic opportunities: Innovators can leverage the patent landscape by identifying claim gaps or designing around claims with modified structures or methods.

  • Legal vigilance: Argentine patent law’s standards necessitate thorough claim interpretation and validity assessments to ensure enforceability and freedom-to-operate.


FAQs

1. What is the primary therapeutic focus of patent AR059682?
It protects a specific chemical compound or formulation intended for use in treating [insert condition], as defined within its claims.

2. How broad are the claims of AR059682?
The claims are tailored to specific compounds and formulations, with independent claims covering core inventions and dependent claims offering narrower protection.

3. Can competitors develop similar drugs without infringing AR059682?
Yes, by designing around the specific compound structures and formulations claimed, provided they do not infringe on the patent’s scope as interpreted in Argentina.

4. Does AR059682 have equivalents in other jurisdictions?
Likely yes, as part of a broader patent family aimed at international protection, including filings in the US, Europe, and Brazil.

5. How does the patent landscape in Argentina influence drug development?
It encourages innovation while requiring careful patent navigation to avoid infringement, fostering a competitive environment that balances patent protection with generic entry opportunities.


Sources:

  1. Argentine Patent Registry, Patent AR059682 documentation.
  2. World Intellectual Property Organization (WIPO) PATENTSCOPE.
  3. Argentina’s Industrial Property Law No. 24,481.
  4. Pharmaceutical patent landscape reports for Latin America.
  5. Patent family databases for filings related to AR059682.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.